(Q30441461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Survey of treatment recommendations for anaplastic oligodendroglioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

anaplastic oligodendroglioma

1 reference

based on heuristic

inferred from title

adult oligodendroglioma

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

Nina Paleologos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

Lauren E Abrey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

10

J Gregory Cairncross

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

David N Louis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Andrew B Lassman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jeffrey J Raizer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Warren Mason

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jonathan Finlay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

David R MacDonald

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Oligodendroglioma Study Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

13 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

314-318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response

29 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Successful chemotherapy for recurrent malignant oligodendroglioma.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Genetic analyses for predictors of radiation response in glioblastoma.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1907408

10.1215/15228517-2007-002

26 November 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17435180%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference